Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy
Clinical Cardiology · 2023
DOI: 10.1002/clc.24138 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Cardiology, 2023. Verfasst von Hossein Salehi Omran und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Defibrillators, Implantable. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Burn Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Department of Cardiology, Rohani Hospital, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
- Department of Cardiology, Babol University of Medical Sciences, Babol, Iran.
Zitieren
APA
Salehi Omran, H., Irilouzadian, R., Hedayati Goudarzi, M. T., & Salehi Omran, M. T. (2023). Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy. Clinical Cardiology. https://doi.org/10.1002/clc.24138
Vancouver
Salehi Omran H, Irilouzadian R, Hedayati Goudarzi MT, Salehi Omran MT. Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy. Clinical Cardiology. 2023. doi:10.1002/clc.24138
BibTeX
@article{SalehiOmran2023,
author = {Salehi Omran, Hossein and Irilouzadian, Rana and Hedayati Goudarzi, Mohammad Taghi and Salehi Omran, Mohammad Taghi},
title = {Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy},
journal = {Clinical Cardiology},
year = {2023},
doi = {10.1002/clc.24138}
}
EUVIMED